FOLH1 and inflammatory bowel disease: GCPII is also robustly increased in the intestinal mucosa of patients with inflammatory bowel disease [11, 12], and a recent paper has shown a similar large elevation in GCPII expression in the brains of patients who died with severe COVID19 [13].